Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Genetic and Cheminformatic Characterization of Mycobacterium tuberculosis Inhibitors Discovered in the Molecular Libraries Small Molecule Repository.
Journal: ACS infectious diseases
Published: March 25, 2025
The Mycobacterium tuberculosis MmpL3 inhibitor MSU-43085 is active in a mouse model of infection.
Journal: Microbiology spectrum
Published: December 11, 2023
A genetic selection for Mycobacterium smegmatis mutants tolerant to killing by sodium citrate defines a combined role for cation homeostasis and osmotic stress in cell death.
Journal: mSphere
Published: September 08, 2023
Discovery and characterization of antimycobacterial nitro-containing compounds with distinct mechanisms of action and in vivo efficacy.
Journal: Antimicrobial agents and chemotherapy
Published: August 23, 2023
Molecular Mechanisms of MmpL3 Function and Inhibition.
Journal: Microbial drug resistance (Larchmont, N.Y.)
Published: February 22, 2023
Therapeutic efficacy of antimalarial drugs targeting DosRS signaling in Mycobacterium abscessus.
Journal: Science translational medicine
Published: February 23, 2022
Artemisia annua and Artemisia afra extracts exhibit strong bactericidal activity against Mycobacterium tuberculosis.
Journal: Journal of ethnopharmacology
Published: April 17, 2020
Inhibiting Mycobacterium tuberculosis DosRST Signaling by Targeting Response Regulator DNA Binding and Sensor Kinase Heme.
Journal: ACS chemical biology
Published: September 27, 2019
Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance.
Journal: Antimicrobial agents and chemotherapy
Published: March 12, 2019
HC2091 Kills Mycobacterium tuberculosis by Targeting the MmpL3 Mycolic Acid Transporter.
Journal: Antimicrobial agents and chemotherapy
Published: December 04, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026